The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Interventional Cardiology Devices-Global Market Insights and Sales Trends 2025
Synopsis
Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems. These procedures use flexible tubes and catheters thin to get way inside blood vessels to perform diagnostic test or to repair heart structures or other damaged vessels, often evading the need to have a surgical operation. Several devices used in these procedures include stent, PTCA balloon and catheters among several others. The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.
The global Interventional Cardiology Devices market size is expected to reach US$ 10200 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Cardiology Devices in various end use industries. The expanding demands from the Hospitals and Ambulatory Surgical Centers, are propelling Interventional Cardiology Devices market. Angioplasty Balloons, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Angioplasty Stents segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Cardiology Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Cardiology Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Cardiology Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Cardiology Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Cardiology Devices covered in this report include Abbott, Acrostak, B. Braun Melsungen, Biosensors International, Boston Scientific Corporation, Cordis Corporation and Edwards Lifesciences Corporation, etc.
The global Interventional Cardiology Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Acrostak
B. Braun Melsungen
Biosensors International
Boston Scientific Corporation
Cordis Corporation
Edwards Lifesciences Corporation
Global Interventional Cardiology Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Cardiology Devices market, Segment by Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Global Interventional Cardiology Devices market, by Application
Hospitals
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Cardiology Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems. These procedures use flexible tubes and catheters thin to get way inside blood vessels to perform diagnostic test or to repair heart structures or other damaged vessels, often evading the need to have a surgical operation. Several devices used in these procedures include stent, PTCA balloon and catheters among several others. The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.
The global Interventional Cardiology Devices market size is expected to reach US$ 10200 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Cardiology Devices in various end use industries. The expanding demands from the Hospitals and Ambulatory Surgical Centers, are propelling Interventional Cardiology Devices market. Angioplasty Balloons, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Angioplasty Stents segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Cardiology Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Cardiology Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Cardiology Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Cardiology Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Cardiology Devices covered in this report include Abbott, Acrostak, B. Braun Melsungen, Biosensors International, Boston Scientific Corporation, Cordis Corporation and Edwards Lifesciences Corporation, etc.
The global Interventional Cardiology Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Acrostak
B. Braun Melsungen
Biosensors International
Boston Scientific Corporation
Cordis Corporation
Edwards Lifesciences Corporation
Global Interventional Cardiology Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Cardiology Devices market, Segment by Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Global Interventional Cardiology Devices market, by Application
Hospitals
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Cardiology Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Interventional Cardiology Devices
1.1 Interventional Cardiology Devices Market Overview
1.1.1 Interventional Cardiology Devices Product Scope
1.1.2 Interventional Cardiology Devices Market Status and Outlook
1.2 Global Interventional Cardiology Devices Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Interventional Cardiology Devices Market Size by Region (2018-2029)
1.4 Global Interventional Cardiology Devices Historic Market Size by Region (2018-2023)
1.5 Global Interventional Cardiology Devices Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Interventional Cardiology Devices Market Size (2018-2029)
1.6.1 North America Interventional Cardiology Devices Market Size (2018-2029)
1.6.2 Europe Interventional Cardiology Devices Market Size (2018-2029)
1.6.3 Asia-Pacific Interventional Cardiology Devices Market Size (2018-2029)
1.6.4 Latin America Interventional Cardiology Devices Market Size (2018-2029)
1.6.5 Middle East & Africa Interventional Cardiology Devices Market Size (2018-2029)
2 Interventional Cardiology Devices Market by Type
2.1 Introduction
2.1.1 Angioplasty Balloons
2.1.2 Angioplasty Stents
2.1.3 Catheters
2.1.4 Plaque Modification Devices
2.1.5 Hemodynamic Flow Alteration Devices
2.2 Global Interventional Cardiology Devices Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Interventional Cardiology Devices Historic Market Size by Type (2018-2023)
2.2.2 Global Interventional Cardiology Devices Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Interventional Cardiology Devices Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Interventional Cardiology Devices Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Interventional Cardiology Devices Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Interventional Cardiology Devices Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Interventional Cardiology Devices Revenue Breakdown by Type (2018-2029)
3 Interventional Cardiology Devices Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.2 Global Interventional Cardiology Devices Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Interventional Cardiology Devices Historic Market Size by Application (2018-2023)
3.2.2 Global Interventional Cardiology Devices Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Interventional Cardiology Devices Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Interventional Cardiology Devices Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Interventional Cardiology Devices Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Interventional Cardiology Devices Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Interventional Cardiology Devices Revenue Breakdown by Application (2018-2029)
4 Interventional Cardiology Devices Competition Analysis by Players
4.1 Global Interventional Cardiology Devices Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interventional Cardiology Devices as of 2022)
4.3 Date of Key Players Enter into Interventional Cardiology Devices Market
4.4 Global Top Players Interventional Cardiology Devices Headquarters and Area Served
4.5 Key Players Interventional Cardiology Devices Product Solution and Service
4.6 Competitive Status
4.6.1 Interventional Cardiology Devices Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Interventional Cardiology Devices Products, Services and Solutions
5.1.4 Abbott Interventional Cardiology Devices Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Acrostak
5.2.1 Acrostak Profile
5.2.2 Acrostak Main Business
5.2.3 Acrostak Interventional Cardiology Devices Products, Services and Solutions
5.2.4 Acrostak Interventional Cardiology Devices Revenue (US$ Million) & (2018-2023)
5.2.5 Acrostak Recent Developments
5.3 B. Braun Melsungen
5.3.1 B. Braun Melsungen Profile
5.3.2 B. Braun Melsungen Main Business
5.3.3 B. Braun Melsungen Interventional Cardiology Devices Products, Services and Solutions
5.3.4 B. Braun Melsungen Interventional Cardiology Devices Revenue (US$ Million) & (2018-2023)
5.3.5 Biosensors International Recent Developments
5.4 Biosensors International
5.4.1 Biosensors International Profile
5.4.2 Biosensors International Main Business
5.4.3 Biosensors International Interventional Cardiology Devices Products, Services and Solutions
5.4.4 Biosensors International Interventional Cardiology Devices Revenue (US$ Million) & (2018-2023)
5.4.5 Biosensors International Recent Developments
5.5 Boston Scientific Corporation
5.5.1 Boston Scientific Corporation Profile
5.5.2 Boston Scientific Corporation Main Business
5.5.3 Boston Scientific Corporation Interventional Cardiology Devices Products, Services and Solutions
5.5.4 Boston Scientific Corporation Interventional Cardiology Devices Revenue (US$ Million) & (2018-2023)
5.5.5 Boston Scientific Corporation Recent Developments
5.6 Cordis Corporation
5.6.1 Cordis Corporation Profile
5.6.2 Cordis Corporation Main Business
5.6.3 Cordis Corporation Interventional Cardiology Devices Products, Services and Solutions
5.6.4 Cordis Corporation Interventional Cardiology Devices Revenue (US$ Million) & (2018-2023)
5.6.5 Cordis Corporation Recent Developments
5.7 Edwards Lifesciences Corporation
5.7.1 Edwards Lifesciences Corporation Profile
5.7.2 Edwards Lifesciences Corporation Main Business
5.7.3 Edwards Lifesciences Corporation Interventional Cardiology Devices Products, Services and Solutions
5.7.4 Edwards Lifesciences Corporation Interventional Cardiology Devices Revenue (US$ Million) & (2018-2023)
5.7.5 Edwards Lifesciences Corporation Recent Developments
6 North America
6.1 North America Interventional Cardiology Devices Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Interventional Cardiology Devices Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Interventional Cardiology Devices Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Interventional Cardiology Devices Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Interventional Cardiology Devices Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Interventional Cardiology Devices Market Dynamics
11.1 Interventional Cardiology Devices Industry Trends
11.2 Interventional Cardiology Devices Market Drivers
11.3 Interventional Cardiology Devices Market Challenges
11.4 Interventional Cardiology Devices Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
